• Frontline
  • Warren Buffett
  • Volvo
  • NASDAQ Composite Index
  • 10 Year Treasury
  • Commercial Banks
  • JPMorgan Chase
  • Emerging Markets
  • Commerce Department
  • Home
  • Practice Management
  • Research & Insights
  • Alternatives
  • ETF Managed Portfolios
  • Home>Video Archive

    Video Archive

    1. Understanding Amazon's Shifting Strategy


      The e-commerce giant's moves this year point to a focus on engaging Prime members and selling more third-party goods, says R.J. Hottovy.

    2. A Shipping Titan Improves Its Competitive Position


      Fed Ex's narrow moat is widening, thanks to improvements in its ground shipping segment.

    3. The Week Ahead: Campbell Soup Leads a Quiet Holiday Week


      Deere also reports this week. Plus, existing home sales, unemployment claims, and durable goods orders.

    4. Investing Insights: GE, Wal-Mart Earnings and Makeovers


      We analyze the reports from GE and Wal-Mart this week; Christine Benz overhauls five investors' portfolios; Russ Kinnel suggests DIY screens; and Aron Szapiro talks tax reform.

    5. Could Tax Reform Boost Capital Gains Distributions?


      A provision in the Senate's bill limits fund managers' ability to use specific share identification, which could lead to higher distributions.

    6. Shrinking Alts Universe Is a Positive for Investors


      Fewer unattractive alts options should help investors focus, says Morningstar's Jason Kephart.

    7. With Reform Looming, Look at These Year-End Tax To-Do's


      There is plenty of uncertainty about the tax code, but considering these strategies before the end of the year is worth your time, says Baird's Tim Steffen.

    8. Is the Market too Enthusiastic About Wal-Mart?


      We're raising our fair value estimate after a better than expected quarter, but underlying profitability and valuation leave us more tempered versus the market's reaction.

    9. Passive's Active Role in Market Behavior


      Vanguard's Fran Kinniry says investors are more focused on costs than ever before, leading to greater inflows to index funds and ETFs.

    10. An Undervalued, Wide-Moat Name in Healthcare


      We think generic competition on Restasis is manageable and that Allergan has an innovative pipeline and strong aesthetics business.

    11. Kinnel's Tips on Do-It-Yourself Fund Screens


      Russ Kinnel shares the top data points investors should screen for when narrowing down the fund universe.

    12. Harsh Realities Ahead for GE


      We still see long-term potential, but after a dividend cut and planned restructuring, we're cutting our fair value estimate to about $26.

    1 - 12 of about 2022 Results